AgomAb Therapeutics NV (AGMB) logo

AgomAb Therapeutics NV (AGMB) insider trading in the last 6 months

3 insiders bought $620K. No sales.

Filings: 18, in the last 6 months
Quality Score: 2, Below Average

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 18 tradesSee all 18 tradesSee it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

Form 4 filings, newest first

BuyDavid R. Epstein$28KDirectorat $5.57 on Nov 17, filed Nov 19
BuyDavid R. Epstein$30KDirectorat $5.99 on Nov 13, filed Nov 16
BuyDavid R. Epstein$30KDirectorat $6.02 on Nov 13, filed Nov 16

From SEC Form 4s, the newest filed Nov 19, 2026 · Insiders have 2 business days to file a trade

15 more filings on AGMB in the last 6 months, for Pro members. See them free →See them: $1 first month →

Pro members see every filing on AGMB with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at AgomAb Therapeutics NV

Insider trades by person

Cluster buys at AGMB

3 insiders bought AGMB in the last 6 months: David R. Epstein, Tim Jasper Knotnerus, and Pierre Thadee Victor Kemula.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about AGMB's insider trades

As of Nov 21, 2026: AgomAb Therapeutics NV (AGMB) has 18 insider filings on record in the last 6 months, the newest filed Nov 19, 2026. Its Quality Score is 2 (Below Average). Scores as of 8:56 PM ET, 15 minutes behind.

Are AGMB insiders buying or selling?

3 insiders bought $620K across 18 filings in the last 6 months. No open-⁠market sales on record. The newest filing: David R. Epstein, Director, bought $28K on Nov 17, 2026. 3 insiders bought AGMB in the last 6 months: David R. Epstein, Tim Jasper Knotnerus, and Pierre Thadee Victor Kemula.

Who are AGMB's biggest insider sellers?

No AGMB insider sold shares on the open market in the last 6 months, as filed on Form 4.

When did an AGMB insider last buy?

David R. Epstein, Director, bought AGMB shares ($28K) on Nov 17, 2026, filed Nov 19, 2026, the newest insider buy on record.

AgomAb Therapeutics NV's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech. AGMB is on this week's insider buys.

Every insider trade, with its stock's score.

Real-time prices, every Form 4 on every stock with its Quality Score, sorting, filters, and optional alerts when the people you follow file.

See the last 30 days of insider tradesSee the last 30 days of insider tradesStart Pro

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

Shares insiders bought or sold themselves, as filed on Form 4. Grants, option exercises, shares withheld for tax, and 10b5-1 plan sales are left out.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.